RENADIRSEN
UNII 4RW6WRD7SW

Substance Identification & Data

This profile provides standardized clinical and technical data for Renadirsen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4RW6WRD7SW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1782108-31-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4RW6WRD7SW
CAS Registry Number
1782108-31-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RENADIRSEN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C152190
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
131801099
Unique identification number in the NCBI database of chemical substances.
INN ID
10371
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Renadirsen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RENADIRSEN

Common Names & Synonyms

RENADIRSEN [INN]
RENAPERSEN

Systematic Nomenclature

RNA, (P-THIO)((2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5C-GM-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5C-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5U-GM-CM-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5C-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5C-AM-AM-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5U-GM-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5C-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5C-AM-UM-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5C-(3'->4')-(2',6'-ANHYDRO-5'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-LYXO-HEXOFURANO)M5C), 3'-(O-(2-HYDROXYETHYL) HYDROGEN PHOSPHOROTHIOATE)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus
NLM
PubChem Compound